NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/11/2026 10:45
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,923.06 mln
Float16.44 mln
Earnings Date05/18/2026
Piotroski F-Score
4
/ 9
Borderline
1-Year Forecast
50.60
Modest upside
Relative Strength
93
/ 100
Top performer
Debt / Equity
0.03
Debt-free
ROE
-32.64
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Sionna Therapeutics Inc. is a Waltham, Massachusetts-based company founded in 2019 and focused solely on finding better treatments for cystic fibrosis. The company has built a broad pipeline of experimental drugs, several of which have already advanced through early and mid-stage clinical trials. Each drug candidate targets a different part of the protein responsible for cystic fibrosis, with the goal of offering patients more effective options than those currently available.
